INSULET CORP
(PODD)CIK 1145197 · SEC filings only
harness minimum not met
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (2)
Board of Directors authorized a program to repurchase up to $125 million of common stock
Received approval from the Board of Directors for a $350 million increase in our share repurchase authorization.
grade
Sector median (Industrial Applications and Services): B+ across 28 graded companies
Resolved promises
Full say-do history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance by basis
26 of 33 guidance figures that were graded or dropped for basis could not be graded on the same basis (79%). Guidance marked “not judged” is in neither number.
| Guidance type | Said | Graded | Dropped | Other |
|---|---|---|---|---|
| Revenue · non-GAAPcannot be graded | 38 | 0 | 26 | 12 |
| Revenue · basis not stated | 8 | 7 | 0 | 1 |
| EPS · non-GAAPcannot be graded | 3 | 0 | 0 | 3 |
Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.
Guidance shown, not graded (41)
We show what was said — with its source filing — but never score it. The line under each statement says why.
- eps guidance q · Aug 5, 2026Adjusted EPS Growth 1 >30%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 5, 2026Total 17.5% - 19.5%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 6, 2026Adjusted EPS Growth 1 >25%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 6, 2026Total 21% - 23%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 6, 2026Total 20% - 22%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Feb 18, 2026Total 25% - 27%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 18, 2026Adjusted EPS Growth 1 >25%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Nov 6, 2025Total 25% - 28%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 7, 2025Total 22% - 25%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 8, 2025Total 23% - 26%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 20, 2025For the year ending December 31, 2025, the Company expects revenue growth of 16% to 20%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Feb 20, 2025For the quarter ending March 31, 2025, the Company expects revenue growth of 22% to 25%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Nov 7, 2024the Company is raising its expected revenue growth to a range of 20% to 21%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Nov 7, 2024the Company expects revenue growth of 12% to 15%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Aug 8, 2024the Company is raising its expected revenue growth to a range of 16% to 19%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 8, 2024the Company expects revenue growth of 18% to 21%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Jul 26, 2024The Company expects to raise its full year 2024 Total Omnipod revenue outlook to a range of 18% to 21%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 9, 2024For the year ending December 31, 2024, the Company is raising its expected revenue growth to a range of 14% to 18%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 9, 2024For the quarter ending June 30, 2024, the Company expects revenue growth of 15% to 18%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 8, 2023the Company expects revenue growth of 18% to 21%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Aug 8, 2023the Company is raising its expected revenue growth of 22% to 25%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 4, 2023the Company expects revenue growth of 27% to 30%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 4, 2023the Company is raising its expected revenue growth of 18% to 22%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Nov 3, 2022the Company is raising its revenue growth guidance range to 18% to 19%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Nov 3, 2022the Company expects revenue growth of 11% to 14%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Aug 4, 2022the Company is raising its revenue growth guidance range to 14% to 17%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 4, 2022the Company expects revenue growth of 17% to 20%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 5, 2022For the quarter ending June 30, 2022, the Company expects revenue growth of 12% to 15%.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 5, 2022For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 23, 2022For the year ending December 31, 2022, the Company expects revenue growth in the range of 12% to 16%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Feb 23, 2022For the quarter ending March 31, 2022, the Company expects revenue growth of 13% to 16%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Nov 4, 2021the Company expects revenue growth of 19% to 25%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Nov 4, 2021the Company is updating its revenue growth guidance range to 18% to 20%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 5, 2021the Company expects revenue growth of 11% to 18%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Aug 5, 2021the Company is reaffirming its revenue guidance range of 16% to 20%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 6, 2021For the year ending December 31, 2021, the Company is raising the low end of its revenue guidance range to 16% to 20%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 6, 2021For the quarter ending June 30, 2021, the Company expects revenue growth of 10% to 14%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Feb 23, 2021For the quarter ending March 31, 2021, the Company expects revenue growth of 20% to 24%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 23, 2021For the year ending December 31, 2021, the Company expects revenue growth in the range of 15% to 20%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · May 7, 2020the Company expects revenue growth of 19% to 23% in constant currencyUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 7, 2020the Company is guiding to approximately 15% in constant currencyUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
Open promises (0) · 1 superseded
For the year ending December 31, 2023, the Company expects revenue growth in the range of 14% to 19%
Credibility timeline
Timeline as a list
- Feb 26, 2020ABOVEthe Company expects revenue in the range of $193 to $201 million
- Feb 26, 2020ABOVEthe Company is raising its revenue guidance to a range of $722 to $730 million
- May 5, 2023ABOVEFor the quarter ending March 31, 2023, the Company expects revenue growth of 11% to 14%
- Feb 23, 2024ABOVEthe Company expects revenue growth of 22% to 25%
- Feb 23, 2024ABOVEthe Company is raising its expected revenue growth to a range of 26% to 27%
- May 10, 2024ABOVEFor the quarter ending March 31, 2024, the Company expects revenue growth of 17% to 20%
- Feb 21, 2025ABOVEFor the year ending December 31, 2024, the Company expects revenue growth in the range of 12% to 17%